Navegar

Colección

Datos Estadísticas

Lista de

cancer prognosis
6
"Non-myogenic tumors display altered expression of dystrophin (DMD) and a high frequency of genetic alterations" (2017) Luce, L.N.; Abbate, M.; Cotignola, J.; Giliberto, F. Oncotarget. 8(1):145-155
"Glyco-nano-oncology: Novel therapeutic opportunities by combining small and sweet" (2016) Hockl, P.F.;Wolosiuk, A.;Pérez-Sáez, J.M. (...)Rabinovich, G.A. Pharmacological Research. 109:45-54
"Delineating the "galectin signature" of the tumor microenvironment" (2013) Compagno, D.;Laderach, J.D.;Gentilini, L. (...)Rabinovich, A.G. OncoImmunology. 2(4)
"Clinical relevance of ErbB-2/HER2 nuclear expression in breast cancer" (2012) Schillaci, R.;Guzmán, P.;Cayrol, F. (...)Elizalde, P.V. BMC Cancer. 12